Literature DB >> 23224099

Genotypic prediction of HIV-1 CRF01-AE tropism.

Stéphanie Raymond1, Pierre Delobel, Sylvie Rogez, Stéphanie Encinas, Patrick Bruel, Christophe Pasquier, Karine Sandres-Sauné, Bruno Marchou, Patrice Massip, Jacques Izopet.   

Abstract

HIV-1 subtype CRF01-AE predominates in south Asia and has spread throughout the world. The virus tropism must be determined before using CCR5 antagonists. Genotypic methods could be used, but the prediction algorithms may be inaccurate for non-B subtypes like CRF01-AE and the correlation with the phenotypic approach has not been assessed. We analyzed 61 CRF01-AE V3 clonal sequences of known phenotype from the GenBank database. The sensitivity of the Geno2pheno10 genotypic algorithm was 91%, but its specificity was poor (54%). In contrast, the combined 11/25 and net charge rule was highly specific (98%) but rather insensitive (64%). We thus identified subtype CRF01-AE determinants in the V3 region that are associated with CXCR4 use and developed a new simple rule for optimizing the genotypic prediction of CRF01-AE tropism. The concordance between the predicted CRF01-AE genotype and the phenotype was 95% for the clonal data set. We then validated this algorithm by analyzing the data from 44 patients infected with subtype CRF01-AE, whose tropism was determined using a recombinant phenotypic entry assay and V3-loop bulk sequencing. The CRF01-AE genotypic tool was 70% sensitive and 96% specific for predicting CXCR4 use, and the concordance between genotype and phenotype was 84%, approaching the concordance obtained for predicting the tropism of HIV-1 subtype B. Genotypic predictions that use a subtype CRF01-AE-specific algorithm appear to be preferable for characterizing coreceptor usage both in pathophysiological studies and for ensuring the appropriate use of CCR5 antagonists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224099      PMCID: PMC3553889          DOI: 10.1128/JCM.02328-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: the ANRS GenoTropism study.

Authors:  Patricia Recordon-Pinson; Cathia Soulié; Philippe Flandre; Diane Descamps; Mouna Lazrek; Charlotte Charpentier; Brigitte Montes; Mary-Anne Trabaud; Jacqueline Cottalorda; Véronique Schneider; Laurence Morand-Joubert; Catherine Tamalet; Delphine Desbois; Muriel Macé; Virginie Ferré; Astrid Vabret; Annick Ruffault; Coralie Pallier; Stéphanie Raymond; Jacques Izopet; Jacques Reynes; Anne-Geneviève Marcelin; Bernard Masquelier
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

2.  Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism.

Authors:  Stéphanie Raymond; Pierre Delobel; Maud Mavigner; Michelle Cazabat; Corinne Souyris; Stéphanie Encinas; Karine Sandres-Sauné; Christophe Pasquier; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

3.  Predicted co-receptor tropism and sequence characteristics of China HIV-1 V3 loops: implications for the future usage of CCR5 antagonists and AIDS vaccine development.

Authors:  Chiyu Zhang; Shungao Xu; Jifu Wei; Hongxiong Guo
Journal:  Int J Infect Dis       Date:  2009-02-12       Impact factor: 3.623

4.  Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage.

Authors:  Stéphanie Raymond; Pierre Delobel; Maud Mavigner; Michelle Cazabat; Corinne Souyris; Stéphanie Encinas; Patrick Bruel; Karine Sandres-Sauné; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  J Clin Virol       Date:  2009-12-16       Impact factor: 3.168

5.  Genotypic characterization of HIV type 1 env gp160 sequences from three regions in Thailand.

Authors:  U Chandimal de Silva; Jiranan Warachit; Nerisa Sattagowit; Chanin Jirapongwattana; Sumolrat Panthong; Piraporn Utachee; Teruo Yasunaga; Kazuyoshi Ikuta; Masanori Kameoka; Naphatsawan Boonsathorn
Journal:  AIDS Res Hum Retroviruses       Date:  2010-02       Impact factor: 2.205

6.  High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.

Authors:  Eduardo Seclén; Carolina Garrido; María del Mar González; Juan González-Lahoz; Carmen de Mendoza; Vincent Soriano; Eva Poveda
Journal:  J Antimicrob Chemother       Date:  2010-04-28       Impact factor: 5.790

Review 7.  European guidelines on the clinical management of HIV-1 tropism testing.

Authors:  L P R Vandekerckhove; A M J Wensing; R Kaiser; F Brun-Vézinet; B Clotet; A De Luca; S Dressler; F Garcia; A M Geretti; T Klimkait; K Korn; B Masquelier; C F Perno; J M Schapiro; V Soriano; A Sönnerborg; A-M Vandamme; C Verhofstede; H Walter; M Zazzi; C A B Boucher
Journal:  Lancet Infect Dis       Date:  2011-03-21       Impact factor: 25.071

8.  A sensitive phenotypic assay for the determination of human immunodeficiency virus type 1 tropism.

Authors:  Nuria González; Mayte Pérez-Olmeda; Elena Mateos; Almudena Cascajero; Amparo Alvarez; Sanne Spijkers; Javier García-Pérez; Sonsoles Sánchez-Palomino; Ezequiel Ruiz-Mateos; Manuel Leal; José Alcami
Journal:  J Antimicrob Chemother       Date:  2010-10-14       Impact factor: 5.790

9.  Genotypic and phenotypic characterization of HIV-1 CRF01_AE env molecular clones from infections in China.

Authors:  Jianhui Nie; Chuntao Zhang; Wei Liu; Xueling Wu; Feng Li; Suting Wang; Fuxiong Liang; Aijing Song; Youchun Wang
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04-01       Impact factor: 3.731

10.  Genotypic prediction of HIV-1 subtype D tropism.

Authors:  Stéphanie Raymond; Pierre Delobel; Marie-Laure Chaix; Michelle Cazabat; Stéphanie Encinas; Patrick Bruel; Karine Sandres-Sauné; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  Retrovirology       Date:  2011-07-13       Impact factor: 4.602

View more
  12 in total

1.  Algorithm-based prediction of HIV-1 subtype D coreceptor use.

Authors:  Julia Dina; Stephanie Raymond; Anne Maillard; Helene Le Guillou-Guillemette; Audrey Rodalec; Agnes Beby-Defaux; Genevieve Giraudeau; Sophie Vallet; Thomas Mourez; Christopher Payan; Astrid Vabret; Annick Ruffault; Virginie Ferre; Jacques Izopet; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

Review 2.  Bioinformatic analysis of HIV-1 entry and pathogenesis.

Authors:  Benjamas Aiamkitsumrit; Will Dampier; Gregory Antell; Nina Rivera; Julio Martin-Garcia; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

3.  Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response.

Authors:  Cathia Soulie; Gilles Peytavin; Charlotte Charpentier; Sidonie Lambert-Niclot; Sophie Sayon; Benoit Visseaux; Anne Simon; Christine Katlama; Yazdan Yazdanpanah; Diane Descamps; Vincent Calvez; Anne-Geneviève Marcelin
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12-17       Impact factor: 2.205

4.  Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism.

Authors:  Hanna B Scinto; Sandeep Gupta; Swati Thorat; Muhammad M Mukhtar; Anthony Griffiths; Jennifer Delgado; Elizabeth Plake; Hemant K Vyas; Amanda Strickland; Siddappa N Byrareddy; David C Montefiori; Celia LaBranche; Ranajit Pal; Jim Treece; Sharon Orndorff; Maria Grazia Ferrari; Deborah Weiss; Agnes-Laurence Chenine; Robert McLinden; Nelson Michael; Jerome H Kim; Merlin L Robb; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Ruth M Ruprecht
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

5.  High proportion of HIV serodiscordance among HIV-affected married couples in northern Vietnam.

Authors:  Ikumi Sawada; Junko Tanuma; Cuong Duy Do; Tra Thu Doan; Quynh Phuong Luu; Lan Anh Thi Nguyen; Tuong Van Thi Vu; Tuan Quang Nguyen; Naho Tsuchiya; Teiichiro Shiino; Lay-Myint Yoshida; Thanh Thuy Thi Pham; Koya Ariyoshi; Shinichi Oka
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

6.  Genotypic prediction of tropism of highly diverse HIV-1 strains from Cameroon.

Authors:  Christelle Mbondji-Wonje; Viswanath Ragupathy; Jiangqin Zhao; Aubin Nanfack; Sherwin Lee; Judith Torimiro; Phillipe Nyambi; Indira K Hewlett
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

7.  Reliable genotypic tropism tests for the major HIV-1 subtypes.

Authors:  Kieran Cashin; Lachlan R Gray; Katherine L Harvey; Danielle Perez-Bercoff; Guinevere Q Lee; Jasminka Sterjovski; Michael Roche; James F Demarest; Fraser Drummond; P Richard Harrigan; Melissa J Churchill; Paul R Gorry
Journal:  Sci Rep       Date:  2015-02-25       Impact factor: 4.379

8.  Possible involvement of distinct phylogenetic clusters of HIV-1 variants in the discrepancies between coreceptor tropism predictions based on viral RNA and proviral DNA.

Authors:  Hiroshi Kotani; Koji Sudo; Naoki Hasegawa; Hiroshi Fujiwara; Tomohisa Hayakawa; Osamu Iketani; Masaya Yamaguchi; Mayumi Mochizuki; Satoshi Iwata; Shingo Kato
Journal:  J Pharm Health Care Sci       Date:  2016-11-09

9.  Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism.

Authors:  Nicolas Jeanne; Adrien Saliou; Romain Carcenac; Caroline Lefebvre; Martine Dubois; Michelle Cazabat; Florence Nicot; Claire Loiseau; Stéphanie Raymond; Jacques Izopet; Pierre Delobel
Journal:  Sci Rep       Date:  2015-11-20       Impact factor: 4.379

10.  Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate.

Authors:  Kenny Dauwe; Virginie Mortier; Marlies Schauvliege; Annelies Van Den Heuvel; Katrien Fransen; Jean-Yves Servais; Danielle Perez Bercoff; Carole Seguin-Devaux; Chris Verhofstede
Journal:  BMC Infect Dis       Date:  2015-11-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.